

Atrial Fibrillation Devices Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Atrial Fibrillation Devices market is expected to reach a value of $8.9 billion by 2027, with a CAGR of 12.3%. The market is driven by the rising prevalence of atrial fibrillation, advancements in technology, and increasing awareness among patients about treatment options. Key players include Medtronic, Boston Scientific, Abbott, and Johnson & Johnson. Request Sample Report
◍ Abbott
◍ Boston Scientific
◍ Biosense Webster
◍ Medtronic
◍ Japan Lifeline
◍ AtriCure
◍ Biotronik
◍ Philips
◍ Synaptic Medical
◍ Osypka AG
◍ MicroPort Scientific
◍ CardioFocus
◍ Lepu Medical
◍ APT Med
◍ TZ Medical
The Atrial Fibrillation Devices Market is highly competitive, with key players including Abbott, Boston Scientific, Medtronic, and Biosense Webster. These companies offer a range of devices for the treatment of atrial fibrillation, including ablation catheters and implantable devices. They drive market growth through innovation and strategic partnerships.
- Abbott: $9.63 billion in sales revenue
- Boston Scientific: $8.39 billion in sales revenue
- Medtronic: $30.56 billion in sales revenue
Request Sample Report
Hospitals ◍ Clinics
◍ Ambulatory Surgical Centers
Others
Request Sample Report
Catheter Ablation
Maze Surgery
Request Sample Report
$ 611.81 Million